...
首页> 外文期刊>International journal of clinical pharmacology and therapeutics >Successful sequential antiangiogenic therapy for alveolar soft part sarcoma - a case report.
【24h】

Successful sequential antiangiogenic therapy for alveolar soft part sarcoma - a case report.

机译:成功的连续抗血管生成疗法治疗肺泡软部分肉瘤-病例报告。

获取原文
获取原文并翻译 | 示例

摘要

Alveolar soft part sarcoma (ASPS) is a rare tumor entity accounting for < 5% of childhood non-rhabdomyosarcoma soft tissue sarcomas. It mainly affects children and young adults and has a poor prognosis because of its resistance to conventional cytotoxic drugs. Randomized clinical trials concerning this tumor entity have not yet been earned out and reports on treatment are usually limited to a small number of cases [2], The tumor is characterized by its high level of vascularization rendering it a potential target for novel treatment regimens with targeted drugs.
机译:肺泡软部分肉瘤(ASPS)是一种罕见的肿瘤实体,占儿童期非横纹肌肉瘤软组织肉瘤的<5%。它主要影响儿童和年轻人,由于其对常规细胞毒性药物的耐药性,因此预后较差。尚未获得有关该肿瘤实体的随机临床试验,有关治疗的报告通常仅限于少数病例[2]。该肿瘤的特点是其高水平的血管生成使其成为新的治疗方案的潜在靶点。靶向药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号